Treatment patterns, adherence, and persistence among psoriasis patients treated with biologics in a real-world setting, overall and by disease severity
Author:
Affiliation:
1. Eli Lilly and Company, Indianapolis, IN, USA;
2. Epidemiology and Drug Safety, IQVIA, Plymouth Meeting, PA, USA;
3. Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, USA
Funder
Eli Lilly and Company
Publisher
Informa UK Limited
Subject
Dermatology
Link
https://www.tandfonline.com/doi/pdf/10.1080/09546634.2018.1479725
Reference19 articles.
1. Psoriasis prevalence among adults in the United States
2. Guidelines of care for the management of psoriasis and psoriatic arthritis
3. Prevalence of Psoriasis Among Adults in the U.S.
4. Interleukin-17 inhibitors. A new era in treatment of psoriasis and other skin diseases
Cited by 22 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Characterizing the Clinical Adoption of Medical AI Devices through U.S. Insurance Claims;NEJM AI;2023-12-11
2. Letter to the Editor: Response to Fitzgerald T et al. Long-Term Psoriasis Control with Guselkumab, Adalimumab, Secukinumab, or Ixekizumab in the USA;Dermatology and Therapy;2023-09-26
3. Characterizing the clinical adoption of medical AI through U.S. insurance claims;2023-08-28
4. Persistence of second-line biologics in psoriasis after first-line biologic failure: a nationwide cohort study from the French health insurance database (SNDS);British Journal of Dermatology;2023-07-21
5. Real-world treatment patterns and healthcare costs in patients with psoriasis taking systemic oral or biologic therapies;Journal of Dermatological Treatment;2023-03-03
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3